Cargando…

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

BACKGROUND: Depression in bipolar I disorder responds to the atypical antipsychotic olanzapine. This subpopulation analysis assessed whether olanzapine is superior to placebo specifically in the treatment of Chinese patients with bipolar I depression. METHODS: This was a subpopulation analysis of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Cheng, Yan, Wang, Jia Ning, Wu, Sheng Hu, Xue, Hai Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003102/ https://www.ncbi.nlm.nih.gov/pubmed/27601902 http://dx.doi.org/10.2147/NDT.S98927

Ejemplares similares

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
por: Katagiri, Hideaki, et al.
Publicado: (2013)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study
por: Earley, Willie R., et al.
Publicado: (2019)

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: A double blind randomized placebo controlled trial
por: Lazowski, Lauren K, et al.
Publicado: (2014)

Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
por: Kato, Tadafumi, et al.
Publicado: (2020)

A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
por: Zhang, Ling, et al.
Publicado: (2022)

Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial
por: Spettigue, Wendy, et al.
Publicado: (2008)

A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
por: Albaugh, Vance L., et al.
Publicado: (2011)

Review of olanzapine in the management of bipolar disorders
por: Narasimhan, Meera, et al.
Publicado: (2007)

Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study
por: Pan, Pei-Yin, et al.
Publicado: (2014)

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
por: Toniolo, Ricardo Alexandre, et al.
Publicado: (2017)

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
por: Katagiri, Hideaki, et al.
Publicado: (2013)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial
por: Wu, Congchong, et al.
Publicado: (2020)

Olanzapine Discontinuation Emergent Recurrence in Bipolar Disorder
por: Arora, Manu, et al.
Publicado: (2014)

Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial
por: Miravalles, Cerena, et al.
Publicado: (2022)

Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial
por: Wang, Lei, et al.
Publicado: (2010)

Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination
por: Walker, Daniel J., et al.
Publicado: (2017)

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
por: Murasaki, Mitsukuni, et al.
Publicado: (2018)

Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
por: Yatham, Lakshmi N., et al.
Publicado: (2020)

Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
por: Katagiri, Hideaki, et al.
Publicado: (2014)

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
por: Savitz, Jonathan B., et al.
Publicado: (2018)

A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation
por: Qiao, Lei, et al.
Publicado: (2021)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
por: Xu, Lei, et al.
Publicado: (2015)

Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Li, Yi-Fan, et al.
Publicado: (2021)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
por: Zhang, Zhenxin, et al.
Publicado: (2018)

Olanzapine induced tardive dystonia in case of adolescent bipolar disorder
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2009)

Paliperidone Extended-Release Tablets for the Treatment of Methamphetamine Use Disorder in Chinese Patients After Acute Treatment: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study
por: Wang, Gang, et al.
Publicado: (2019)

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
por: Savitz, Jonathan, et al.
Publicado: (2012)

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study
por: Zhao, Y., et al.
Publicado: (2021)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

The Efficacy of Probiotics for Treatment of Bipolar Disorder-Type 1: A Randomized, Double-Blind, Placebo Controlled Trial
por: Eslami Shahrbabaki, Mahin, et al.
Publicado: (2020)

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
por: Liu, Chao, et al.
Publicado: (2019)

Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence
por: Donoghue, Kim, et al.
Publicado: (2020)

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III, randomized, double‐blind, placebo‐controlled trial
por: Peng, Li Hua, et al.
Publicado: (2022)

Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder
por: Inoue, Takeshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e8srkv9oefaj4d45bt5892g9ps